Detalhe da pesquisa
1.
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study.
Lancet
; 403(10423): 271-281, 2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071986
2.
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic, Omalizumab, in Severe Asthma in Adults: Results of the SoMOSA Study.
Am J Respir Crit Care Med
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635834
3.
Exploring Definitions and Predictors of Severe Asthma Clinical Remission Post-Biologic in Adults.
Am J Respir Crit Care Med
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38701495
4.
Ethnic variation in asthma phenotypic presentation and outcomes: a cross-sectional analysis of the UK Biobank.
Thorax
; 79(2): 186-190, 2024 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071553
5.
Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care.
Thorax
; 79(5): 403-411, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38124220
6.
Barriers to clinical remission in severe asthma.
Respir Res
; 25(1): 178, 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38658975
7.
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma.
Ann Allergy Asthma Immunol
; 132(5): 610-622.e7, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38151100
8.
Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma control.
J Allergy Clin Immunol
; 152(4): 876-886, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37315813
9.
Randomised controlled trial for the titration of oral corticosteroids using markers of inflammation in severe asthma.
Thorax
; 78(9): 868-874, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36948587
10.
Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study.
Thorax
; 78(7): 643-652, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35922128
11.
Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry.
Eur Respir J
; 62(6)2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37857423
12.
Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA).
Eur Respir J
; 61(4)2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36229046
13.
Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both.
Allergy
; 78(7): 1934-1948, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36929509
14.
Mass spectrometry in the clinical laboratory. A short journey through the contribution to the scientific literature by CCLM.
Clin Chem Lab Med
; 61(5): 873-879, 2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282951
15.
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes.
Am J Respir Crit Care Med
; 206(5): 545-553, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35549845
16.
Socioeconomic disparities in asthma health care utilization, exacerbations, and mortality: A systematic review and meta-analysis.
J Allergy Clin Immunol
; 149(5): 1617-1627, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34673047
17.
An observational study to determine the relationship between cough frequency and markers of inflammation in severe asthma.
Eur Respir J
; 60(6)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777770
18.
Benefits of specialist severe asthma management: demographic and geographic disparities.
Eur Respir J
; 60(6)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777771
19.
Glucocorticoid toxicity reduction with mepolizumab using the Glucocorticoid Toxicity Index.
Eur Respir J
; 59(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34210787
20.
Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study.
Eur Respir J
; 60(6)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35896216